key: cord-0813694-bldv2efi authors: Llupià, Anna; de la Torre‐Pérez, Laura; Granés, Laura; Olivé, Victòria; Baron‐Miras, Lourdes; Torà, Isabel; Marin, Clara; Grau, Jaume; Soriano, Inmaculada; Roel, Elena; García‐Diez, Marta; López‐Toribio, María; Puig, Joaquim; Guinovart, Caterina; Santana, Gemina; Fernández‐Torres, Paula; García‐Basteiro, Alberto L.; Prat, Andreu; Blanco‐Rojas, Beatriz Julieta; de Arquer, Maria; Barroso, Sonia; Tortajada, Marta; Varela, Pilar; Vilella, Anna; Trilla, Antoni title: SARS‐CoV2 hospital surveillance and control system with contact tracing for patients and health care workers at a large reference hospital in Spain during the first wave: An observational descriptive study date: 2022-02-26 journal: Health Sci Rep DOI: 10.1002/hsr2.513 sha: adbb4fc5457bf4151e99e80a3e25874033fe5c88 doc_id: 813694 cord_uid: bldv2efi BACKGROUND AND AIMS: During the first peak of the COVID‐19 pandemic, the Preventive Medicine Department and the Occupational Health Department at Hospital Clinic de Barcelona (HCB), a large Spanish referral hospital, developed an innovative comprehensive SARS‐CoV2 Surveillance and Control System (CoSy‐19) in order to preserve patients' and health care workers' (HCWs) safety. We aim to describe the CoSy‐19 and to assess the impact in the number of contacts that new cases generated along this time. METHODS: Observational descriptive study of the findings of the activity of contact tracing of all cases received at the HCB during the first peak of COVID‐19 in Spain (February 25th‐May 3rd, 2020). RESULTS: A team of 204 professionals and volunteers performed 384 in‐hospital contact‐tracing studies which generated contacts, detecting 298 transmission chains which suggested preventive measures, generated around 22 000 follow‐ups and more than 30 000 days of work leave. The number of contacts that new cases generated decreased during the study period. CONCLUSION: Coordination between Preventive Medicine and Occupational Health departments and agile information systems were necessary to preserve non‐COVID activity and workers safety. The novel coronavirus disease (COVID-19) caused by SARS-CoV2 was first detected in Wuhan, China, in late 2019 and then rapidly spread to the rest of the world. 17 We aim to describe the CoSy-19, its findings in-hospital transmission during the first months of the first wave of the pandemic, and to assess the impact in the number of contacts that new cases generated along this time. Cases were classified as confirmed (positive qPCR), probable (clinical and radiologic findings, not microbiologically confirmed), and suspected (compatible symptoms). The CoSy-19 identified Intra-hospital contacts among patients and HCWs who had been exposed to a case more than 15 minutes, less than 2 m apart and without proper PPE from a case, probable or confirmed, in the last 48 hours before symptom onset of the case. During the study period, qPCR tests were not always available: all suspected cases were tested until March 14th, 2020. From this date to March 28th, 2020, only HCW and patients with admission criteria were tested, and later on, only HCWs were tested. During the study period, if a contact of a case developed symptoms during the follow-up, it was considered a secondary case, and defined a chain of transmission together with the primary case. A set of cases linked by chains of transmission was named a cluster. For every case, we registered the reporting date, its classification as HCW or patient, the probable date of onset, and a list of intra-hospital contacts, either patients or HCWs, with the date of last contact and place of exposure. New positive SARS-CoV-2 RT-qPCR tests for both patients and HCWs and probable non-confirmed patient cases were registered in the electronic Hospital Information System (HIS), which runs on SAP software. Initially, probable cases were not registered as such by the electronic system in a standardized form, delaying case identification by the CoSy-19 and the start of the contact tracing. To account for this, and timely identify both confirmed and probable cases, an electronic marker (sticker) was added to the SAP platform. Attending physicians or a positive microbiological result could activate the sticker. These stickers generated a daily list of cases that the Preventive Medicine Department verified. Direct notification by phone or email from HCWs was encouraged. HCWs were asked to fill in an electronic epidemiological questionnaire with information about their signs, symptoms and close contacts. The questionnaire was programmed in Research Electronic Data Capture, REDCap, 9 and HCWs could access it through their smartphones while waiting to be tested or fill it in later, once they received a positive result. The information they provided had to be confirmed by the contact tracers through a phone call. Contact tracers recorded data on cases and close contacts in spreadsheets before being uploaded to Go.Data software, 8, 11 developed by WHO for early outbreak investigation, by a data manager and administrative staff. Medical students conducted the contacts' follow-up through Go.Data dashboards. We computed the number of contacts generated by each case by the CoSy-19, along with the number of cases previously registered as contacts. Means and percentages were calculated. Of these transmission chains, we registered how many had a HCW or patient as primary and secondary cases. We plot the daily count of cases that generated contacts in CoSy-19, and the mean number of contacts by case. We also plot the chains of transmission by date of onset of primary and secondary cases for those whose date of onset had been recorded correctly. We used R Statistical Software version 4.0. 13 Code for the figures is available in the Data S1. In this study, we describe CoSy-19, a hospital surveillance and control system designed specifically for COVID-19. Only a few systems have been described in the medical literature. 2, 6 The rapid scale-up of resources and information tools allowed to detect and interrupt intra- The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. Anna Llupià had full access to all of the data in this study and takes complete responsibility for the integrity of the data and the accuracy of the data analysis. The lead author (manuscript guarantor) affirms that this manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained. The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy restrictions. The computer code to generate the graphics and analyze the data is available as a supplementary material. After consultation in April 2020, the hospital ethics committee stated that ethics review was not necessary because the study met the criteria for the description of operational improvement activities and was exempt from ethics review. https://orcid.org/0000-0001-8284-7560 Conceptualization: Anna Llupià Data Curation: Anna Llupià, Laura Granés, Victòria Olivé Investigation: Anna Llupià Writing -original Draft Preparation: Anna Llupià All authors have read and approved the final version of the REFERENCES Nosocomial transmission and outbreaks of coronavirus disease 2019: the need to protect both patients and healthcare workers Multipronged infection control strategy to achieve zero nosocomial coronavirus disease 2019 (COVID-19) cases among Hong Kong healthcare workers in the first 300 days of the pandemic Surveillance of the infection prevention and control practices of healthcare workers by an infection control surveillance-working group and a team of infection control coordinators during the COVID-19 pandemic European Centre for Disease Prevention and Control. Resource estimation for contact tracing, quarantine and monitoring activities for COVID-19 cases in the EU/EEA Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing Preventing intra-hospital infection and transmission of coronavirus disease 2019 in health-care workers Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital Global Outbreak Alert & Response Network. Geneva: WHO Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period Still using MS Excel? Implementation of the WHO Go.Data software for the COVID-19 contact tracing The electronic medical record and COVID-19: is it up to the challenge? R: A Language and Environment for Statistical Computing (Manual) Covid-19: the precarious position of Spain's nursing homes Personal protective equipment and intensive care unit healthcare worker safety in the COVID-19 era (PPE-SAFE): an international survey Risk of nosocomial transmission of coronavirus disease 2019: an experience in a general ward setting in Hong Kong Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (Covid-19). Geneva: World Health Organisation Additional supporting information may be found in the online version of the article at the publisher's website.